Concepedia

Daniel R. Cerven

DR

7

Publications

164

Citations

7

H-Index

1983

Active since

Affiliations

MB Research Laboratories(Current)

Ventria Bioscience (United States)

Daniel R. Cerven is an author at MB Research Laboratories specializing in medicine, ophthalmology, and toxicology.

Top concepts

Publications per year

1983–2011

7

Publications

7

28-Day repeated dose oral toxicity of recombinant human apo-lactoferrin or recombinant human lysozyme in rats

Daniel R. Cerven, George DeGeorge, Delia R. Bethell · Regulatory Toxicology and Pharmacology · 2008 · 30 citations

, , +7

28-Day repeated dose oral toxicity of recombinant human holo-lactoferrin in rats

Daniel R. Cerven, George DeGeorge, Delia R. Bethell · Regulatory Toxicology and Pharmacology · 2008 · 29 citations

, , +6

Porcine Corneal Ocular Reversibility Assay (PorCORA) predicts ocular damage and recovery for global regulatory agency hazard categories

Michelle Piehl, Micheal Carathers, Rachel Soda et al. · Toxicology in Vitro · 2011 · 27 citations

, , +3

Novel cultured porcine corneal irritancy assay with reversibility endpoint

Michelle Piehl, Albert Gilotti, Alison Donovan et al. · Toxicology in Vitro · 2009 · 25 citations

, , +2

Assessment of the chorioallantoic membrane vascular assay (CAMVA) in the COLIPA in vitro eye irritation validation study

D.M. Bagley, Daniel R. Cerven, John W. Harbell · Toxicology in Vitro · 1999 · 22 citations

, , +5

Rows per page

1–5 of 7